Comparison between ResGen IPO and Sudarshan Pharma Industries IPO.
ResGen IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Sudarshan Pharma Industries IPO is a SME Bookbuilding proposed to list at BSE SME.
| ResGen IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Gretex Corporate Services Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of ResGen IPO is up to ₹26.79 Cr whereas the issue size of the Sudarshan Pharma Industries IPO is up to ₹47.58 Cr. The final issue price of ResGen IPO is ₹47.00 per share and of Sudarshan Pharma Industries IPO is ₹73.00 per share.
| ResGen IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹45.00 per share | ₹71.00 per share |
| Issue Price (Upper) | ₹47.00 per share | ₹73.00 per share |
| Issue Price (Final) | ₹47.00 per share | ₹73.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1600 shares |
| Fresh Issue Size | 57,00,000 shares | 65,18,400 shares |
| Fresh Issue Size (Amount) | up to ₹26.79 Cr | up to ₹47.58 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,00,000 shares | 65,18,400 shares |
| Issue Size Total (Amount) | up to ₹26.79 Cr | up to ₹47.58 Cr |
ResGen IPO opens on Feb 28, 2023, while Sudarshan Pharma Industries IPO opens on Mar 09, 2023. The closing date of ResGen IPO and Sudarshan Pharma Industries IPO is Mar 02, 2023, and Mar 14, 2023, respectively.
| ResGen IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| Anchor Bid Date | Feb 27, 2023 | Mar 08, 2023 |
| Issue Open | Feb 28, 2023 | Mar 09, 2023 |
| Issue Close | Mar 02, 2023 | Mar 14, 2023 |
| Basis Of Allotment (Tentative) | Mar 08, 2023 | Mar 17, 2023 |
| Initiation of Refunds (Tentative) | Mar 09, 2023 | Mar 20, 2023 |
| Credit of Share (Tentative) | Mar 10, 2023 | Mar 21, 2023 |
| Listing date (Tentative) | Mar 13, 2023 | Mar 22, 2023 |
| Anchor Lockin End date 1 | Apr 07, 2023 | Apr 16, 2023 |
| Anchor Lockin End date 2 | Jun 06, 2023 | Jun 15, 2023 |
ResGen IPO P/E ratio is 27.33, as compared to Sudarshan Pharma Industries IPO P/E ratio of 24.33.
| ResGen IPO | Sudarshan Pharma Industries IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 94.15 | 80.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 67.22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 27.33 | 24.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹98.58 Cr. | ₹175.68 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20 | 17.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.57 | 38.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.54 | 1.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹17.90 | ₹5.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20 | 17.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the ResGen IPO Retail Individual Investors (RII) are offered 19,98,000 shares while in Sudarshan Pharma Industries IPO retail investors are offered 19,98,000 shares. Qualified Institutional Buyers (QIB) are offered 11,28,000 shares in ResGen IPO and 5,21,600 shares in Sudarshan Pharma Industries IPO.
| ResGen IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | 16,92,000 shares | 7,80,800 shares |
| Market Maker Reservation | 3,00,000 shares | 3,44,000 shares |
| QIB | 11,28,000 shares | 5,21,600 shares |
| NII | 8,82,000 shares | 15,64,800 shares |
| RII | 19,98,000 shares | 36,51,200 shares |
| Employee | ||
| Others | ||
| Total | 57,00,000 shares | 65,18,400 shares |
ResGen IPO subscribed 2.50x in total, whereas Sudarshan Pharma Industries IPO subscribed 1.06x.
| ResGen IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| QIB (times) | 1.09x | 1.01x |
| NII (times) | 3.87x | 0.81x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.88x | 1.20x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.50x | 1.06x |
